These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3678742)

  • 1. Effect of cholecystokinin and of its antagonist, of atropine, and of food on the release of immunoglobulin A and immunoglobulin G specific antibodies in the rat intestine.
    Freier S; Eran M; Faber J
    Gastroenterology; 1987 Dec; 93(6):1242-6. PubMed ID: 3678742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bombesin: an activator of specific Aeromonas antibody secretion in rat intestine.
    Jin GF; Guo YS; Houston CW
    Dig Dis Sci; 1989 Nov; 34(11):1708-12. PubMed ID: 2582984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of atropine and a cholecystokinin receptor antagonist on pancreatic secretion.
    Adler G; Reinshagen M; Koop I; Göke B; Schafmayer A; Rovati LC; Arnold R
    Gastroenterology; 1989 Apr; 96(4):1158-64. PubMed ID: 2647576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin is a regulator of intestinal phase-stimulated PP release.
    Adler G; Beglinger C; Braun U; Reinshagen M; Koop I; Schafmayer A
    Regul Pept; 1990 Sep; 30(2):105-11. PubMed ID: 2274676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proglumide inhibits cholecystokinin and meal-stimulated pancreatic secretion and release of pancreatic polypeptide.
    Beauchamp RD; Gomez G; Nealon WH; Townsend CM; Greeley GH; Thompson JC
    Surgery; 1990 Sep; 108(3):553-8. PubMed ID: 2396199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of specific Aeromonas antibody secretion in rat intestine by gamma-aminobutyric acid.
    Jin GF; Guo YS; Houston CW
    Dig Dis Sci; 1989 Apr; 34(4):617-22. PubMed ID: 2702891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cholecystokinin antagonist, proglumide, increases food intake in the rat.
    Shillabeer G; Davison JS
    Regul Pept; 1984 Apr; 8(3):171-6. PubMed ID: 6463283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the cholecystokinin antagonist, proglumide, on prolactin secretion in the rat.
    Vijayan E; McCann SM
    Life Sci; 1987 Feb; 40(7):629-34. PubMed ID: 3807652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of pentagastrin- and cholecystokinin-stimulated exocrine secretion by proglumide.
    Loewe CJ; Grider JR; Gardiner J; Vlahcevic ZR
    Gastroenterology; 1985 Oct; 89(4):746-51. PubMed ID: 2863192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
    Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
    J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of loxiglumide, a cholecystokinin antagonist, on pancreatic polypeptide release in humans.
    Meier R; Hildebrand P; Thumshirn M; Albrecht C; Studer B; Gyr K; Beglinger C
    Gastroenterology; 1990 Dec; 99(6):1757-62. PubMed ID: 2227288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proglumide, a cholecystokinin antagonist, increases gastric emptying in rats.
    Shillabeer G; Davison JS
    Am J Physiol; 1987 Feb; 252(2 Pt 2):R353-60. PubMed ID: 3812772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin-induced release of IgA antibodies in rat intestine.
    Freier S; Eran M; Abrahamov A
    Adv Exp Med Biol; 1987; 216A():413-7. PubMed ID: 3687532
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of proglumide on cholecystokinin-, bombesin-, and glucagon-induced satiety in the rat.
    Collins S; Walker D; Forsyth P; Belbeck L
    Life Sci; 1983 May; 32(19):2223-9. PubMed ID: 6843294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas.
    Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
    Gastroenterology; 1989 Feb; 96(2 Pt 1):462-9. PubMed ID: 2910761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin facilitates ejaculation in male rats: blockade with proglumide and apomorphine.
    Pfaus JG; Phillips AG
    Eur J Pharmacol; 1987 Sep; 141(3):331-8. PubMed ID: 3666030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo comparison of inhibition with proglumide and CR-1409 of cholecystokinin-induced pressure in the biliary tract of the guinea pig.
    Poston GJ; MacLellan DG; Hashimoto T; Upp JR; Townsend CM; Thompson JC
    Surg Gynecol Obstet; 1990 Mar; 170(3):217-22. PubMed ID: 2305348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction and CCK secretion in humans.
    Mitsukawa T; Takemura J; Nishizono F; Nakatsuru K; Ohgo S; Matsukura S
    Am J Gastroenterol; 1989 Nov; 84(11):1371-4. PubMed ID: 2683738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
    Price DD; von der Gruen A; Miller J; Rafii A; Price C
    Anesth Analg; 1985 Aug; 64(8):801-6. PubMed ID: 4014744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.